drug · small molecule
fosmanogepix
Phase 3updated 3mo agoby Basilea Pharmaceutica Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
targets
GPI-anchored wall transfer protein 1
all catalysts(0)
nothing on the calendar yet
Trials studying fosmanogepix
- phase3A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
- phase3A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
- phase1A Study of Fosmanogepix in Healthy Adult Chinese Subjects
- phase1A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.
- phase2Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds
- —Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that